HPA029313

antibody from Atlas Antibodies

Targeting: MASP2 MASP1P1

Western blot (Data presented on provider website)

Immunocytochemistry (Data presented on provider website)

Antibody Data

Product number

HPA029313

Provider

Atlas Antibodies

Proper citation

Atlas Antibodies Cat#HPA029313, RRID:AB_10669654

Product name

Anti-MASP2

Antibody type

Polyclonal

Description

Polyclonal Antibody against Human MASP2, Gene description: mannan-binding lectin serine peptidase 2, Alternative Gene Names: MASP1P1, Validated applications: WB, ICC, Uniprot ID: O00187, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

100 µl

Concentration

0.2 mg/ml

Storage

Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Handling

The antibody solution should be gently mixed before use.

References

Submitted references

SARS-CoV-2 Nucleocapsid Protein Is Not Responsible for Over-Activation of Complement Lectin Pathway

Kocsis A, Bartus D, Hirsch E, Józsi M, Hajdú I, Dobó J, Balczer J, Pál G, Gál P
International Journal of Molecular Sciences 2024;25(13):7343

---

Complement Activation via the Lectin and Alternative Pathway in Patients With Severe COVID-19

Niederreiter J, Eck C, Ries T, Hartmann A, Märkl B, Büttner-Herold M, Amann K, Daniel C
Frontiers in Immunology 2022;13

---

Distinct Roles of Classical and Lectin Pathways of Complement in Preeclamptic Placentae

Belmonte B, Mangogna A, Gulino A, Cancila V, Morello G, Agostinis C, Bulla R, Ricci G, Fraggetta F, Botto M, Garred P, Tedesco F
Frontiers in Immunology 2022;13

---

Complement Activation in Kidneys of Patients With COVID-19

Pfister F, Vonbrunn E, Ries T, Jäck H, Überla K, Lochnit G, Sheriff A, Herrmann M, Büttner-Herold M, Amann K, Daniel C
Frontiers in Immunology 2021;11

---

Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases

Magro C, Mulvey J, Berlin D, Nuovo G, Salvatore S, Harp J, Baxter-Stoltzfus A, Laurence J
Translational Research 2020;220

---

Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19

Laurence J, Mulvey J, Seshadri M, Racanelli A, Harp J, Schenck E, Zappetti D, Horn E, Magro C
Clinical Immunology 2020;219

---

The differing pathophysiologies that underlie COVID‐19‐associated perniosis and thrombotic retiform purpura: a case series

Magro C, Mulvey J, Laurence J, Sanders S, Crowson A, Grossman M, Harp J, Nuovo G
British Journal of Dermatology 2020;184(1):141-150